(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/crwe_tech.jpg

Your Technology Source, Your Technology Team

Server Maintenance, Web Development, Mobile Application Solutions, SEO Services and more

Contact Us: contact@crwetech.com

www.CRWETech.com

ad2

http://crweworld.com/assets/images/ad/ad4.png

Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!

Contact Us: contact@crweworld.com

www.CRWEWorld.com

ad3

http://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

http://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com

ad5

http://crweworld.com/assets/images/ad/Pathology_Laboratories.png

Quest Diagnostics Inc. (NYSE:DGX) offers the most extensive clinical testing network in the U.S. The Company's extensive test menu includes routine biological testing; complex and specialized molecular and gene-based testing, and anatomic pathology testing. These services primarily help identify disease or risk factors for disease and predict and monitor response to treatment.

www.QuestDiagnostics.com






24 Result: PCT

Hitachi Chemical Signs Agreement to Purchase from Caladrius Biosciences the Remaining 80.1% Interest in PCT for $75 Million

March 16th, 2017

Caladrius expected to emerge as a well-capitalized cell therapeutics-only development company with multiple proprietary technology platforms Conference call begins tomorrow, March 17, 2017 at 8:30 am Eastern time BASKING RIDGE, N.J. / CRWE PRES. Read more

Caladrius Biosciences Subsidiary PCT, LLC Enters Into Global Collaboration and License Agreement with Hitachi Chemical

March 14th, 2016

Caladrius Sells 19.9% equity stake in PCT for $19.4 million Licenses cell therapy technology for certain Asian territories for $5.6 million and future royalties BASKING RIDGE, N.J. / CRWEPRESSRELEASE / March 14, 2016 — Caladrius Bios. Read more

International Shipholding Corporation Provides Update on Implementation of Strategic Plan

December 10th, 2015

Mobile, Alabama / CRWEPRESSRELEASE / December 10, 2015 - International Shipholding Corporation (NYSE: ISH) (the “Company” or “ISH”) today provided an update on the implementation of its Strategic Plan. As announced on November. Read more

Caladrius Announces Publication of Two-Year Results from Phase 1 Trial of Type 1 Diabetes Product Candidate in Science Translational Medicine

December 01st, 2015

Study demonstrated persistence of Tregs, safety and feasibility; supports upcoming Phase 2 study to test efficacy of the therapy Basking Ridge, NJ / CRWEPRESSRELEASE / December 1, 2015 – Caladrius Biosciences, Inc. (“Caladrius&rdq. Read more

Amfil Technologies Inc. Files Provisional Patent Application with the United States Patent and Trademark Office for GROzone Technology Protection; Receives Patent Pending Number

August 03rd, 2015

TORONTO, ON / CRWEPRESSRELEASE / August 3, 2015 / Amfil Technologies Inc. (OTCMKTS:AMFE) (OTCMKTS:AMFE), provider of custom engineering and integration of ozone based technology for the medical marijuana manufacturing industry through the GROzone lin. Read more

SeeThruEquity Issues Update on Pressure BioSciences (OTCQB: PBIO) Highlighting Robust Growth in 2015 and Recent Above Market Equity Offering

August 03rd, 2015

NEW YORK, NY / CRWEPRESSRELEASE / August 3, 2015 / SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has issued an update on Pressure BioSciences, In. Read more

Pressure BioSciences (PBIO) Showing Significant Potential for Continued Growth

July 30th, 2015

PHOENIX, AZ / CRWEPRESSRELEASE / July 30, 2015 / Months ago Uptick looked at Pressure BioSciences (OTCMKTS:PBIO), following the release of a Zacks Small-Cap report from April on the company and the award of over a million dollars in grant funding. . Read more

Critical Advancements in Bioscience Make for Breakthrough Investment Opportunities

June 12th, 2015

HOUSTON, TX / CRWEPRESSRELEASE / June 12, 2015 / Advancements in science have moved leaps and bounds ahead in the past 50 years, and continue to grow at a break-neck pace. Creating more efficient ways to examine, experiment, and catalog new studi. Read more

Enertopia Provides Canadian Medical Cannabis Update

June 12th, 2015

VANCOUVER, BC / CRWEPRESSRELEASE / June 12, 2015 / Enertopia Corporation (OTCMKTS:ENRT) (CNSX:TOP) (the "Company" or "Enertopia") announces updates with respect to the Burlington and The Green Canvas Joint Ventures. Enertopia has signed a binding . Read more

Lexaria Files New Patent Pendings

June 11th, 2015

Lexaria Files U.S. Utility and International Patent Applications Encompassing Expanded Uses for Its Core Technology KELOWNA, BC / CRWEPRESSRELEASE / June 11, 2015 / Lexaria, Corp. (OTCMKTS:LXRP) (CNSX:LXX) ("Lexaria" or the "Company") provides the f. Read more

University of Texas at El Paso (UTEP) Develops a Potential Cancer Immunotherapy Drug with Premier Biomedical, Inc. Sponsorship

June 04th, 2015

EL PASO, TX / CRWEPRESSRELEASE / June 4, 2015 / Premier Biomedical, Inc. (OTCMKTS:BIEI), announced that their sponsored partner in R&D, the University of Texas at El Paso (UTEP) (http://www.utep.edu/), has developed a unique antibody against three im. Read more

SeeThruEquity Issues Update on Pressure BioSciences, Increases Price Target to $2.18 Per Share

April 23rd, 2015

NEW YORK, NY / CRWEPRESSRELEASE / April 23, 2015 / SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued an update on P. Read more

PBI Signs Contract with UTEP for Cancer Treatment Methodology Protocol Shown to Greatly Increase Survival and Prevention of Breast Cancer Metastasis

April 16th, 2015

EL PASO, TX / CRWEPRESSRELEASE / April 16, 2015 / Premier Biomedical Inc. (OTCQB:BIEI) signed a Patent License Agreement with the University of Texas El Paso (UTEP), covering the cancer treatment process called "CD152-LDMC" which the two entities hav. Read more

SEC Charges North Carolina Executive With Fraud

April 01st, 2015

Redistributed by CRWEPRESSRELEASE: The Securities and Exchange Commission today charged the owner and chief executive of a North Carolina business with defrauding a publicly-traded telecommunications company and its shareholders during and after its. Read more

ChroMedX Submits US Provisional Patent Application for Recently Developed Aspects of HemoPalm Blood Analysis System

March 10th, 2015

TORONTO, ON / CRWEPRESSRELEASE / March 10, 2015 / ChroMedX Corp. (CNSX:CHX) (OTCMKTS: MNLIF) (EIY2.F) (the "Company"), a developer of in vitro diagnostics and point-of-care testing (POCT) technologies is pleased to announce the filing of a second US . Read more

Load More Content